Vericel Corporation Logo

Email this page: News Release

Treatment With Aastrom's Ixmyelocel-T Shown to Reduce Incidence of Major Adverse Cardiovascular Events in Patients With Ischemic Dilated Cardiomyopathy

For security reasons, registration is required before you can use this feature.
* Indicates required field